Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | GO-203-2C |
Synonyms | |
Therapy Description |
GO-203-2C is a small peptide that binds to mucin (MUC1) at cell membrane, thereby blocking mucin homodimerization and downstream signaling, which leads to antitumor effects (PMID: 26267657). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GO-203-2C | GO-203-2C is a small peptide that binds to mucin (MUC1) at cell membrane, thereby blocking mucin homodimerization and downstream signaling, which leads to antitumor effects (PMID: 26267657). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02204085 | Phase Ib/II | GO-203-2C | A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia | Active, not recruiting | USA | 0 |